AZ is hoping that Fasenra (benralizumab) could join rival drugs from Sanofi/Regeneron and GlaxoSmithKline as approved therapies for chronic rhinosinusitis with nasal polyps (CRSwNP) that have been ...
UPDATED: Friday, Jan. 3 at 2:45 p.m. ET GSK’s IL-5 inhibitor Nucala scored a nod in China to treat people with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP), a ...
A patient-reported outcome (PRO) measure consisting of verbal response scales to assess symptoms of chronic rhinosinusitis with nasal polyps (CRSwNP) was well understood by patients and focused on the ...
WILMINGTON, Del., November 08, 2024--Positive high-level results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]) showed that ...
According to Future Market Insights, the global nasal allergy treatment market is poised for substantial growth, with its valuation expected to double from USD 6.6 billion in 2022 to USD 13.3 billion ...
It is under development for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) and eosinophilic chronic rhinosinusitis, nasal polyposis, chronic spontaneous urticaria, ...
After a 69-day strike, Las Vegas culinary workers at Virgin Hotels have reached a new five-year contract. The strike, marked by contentious negotiations and public demonstrations, centered on ...
Jan. 23, 2025 — Researchers have uncovered which genes on the Y chromosome regulate the development of sperm and impact fertility in male mice. This research could help us understand why some ...
Mr Bing Foods Inc. of New York, NY, is recalling Mr. Bing brand Sriracha Chili Sauce because the product may contain spoilage organisms. According to the details published online by the Food and ...
Ukrainian forces described a different kind of enemy, fighting with unfamiliar tactics and little option to retreat. By Marc Santora and Helene Cooper Rupert Murdoch’s News Group Newspapers ...
Trump Asserts a Muscular Vision of Presidential Power as He Takes Over In a flurry of executive actions, President Trump revived disputed claims of broad presidential authority from his first term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback